Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(2), P. 242 - 242
Published: Feb. 19, 2024
Premature
ovarian
insufficiency
(POI),
also
known
as
premature
menopause
or
failure,
signifies
the
partial
complete
loss
of
endocrine
function
and
fertility
before
40
years
age.
This
condition
affects
approximately
1%
women
childbearing
Although
5-10%
patients
may
conceive
naturally,
conventional
infertility
treatments,
including
assisted
reproductive
technology,
often
prove
ineffective
for
majority.
For
infertile
with
POI,
oocyte
donation
adoption
exist,
although
a
prevalent
desire
persists
among
them
to
have
biological
children.
Stem
cells,
which
are
characterized
by
their
undifferentiated
nature,
self-renewal
capability,
potential
differentiate
into
various
cell
types,
emerged
promising
avenues
treating
POI.
therapy
can
potentially
reverse
diminished
restore
fertility.
Beyond
direct
POI
therapy,
stem
cells
show
promise
in
supplementary
applications
such
tissue
cryopreservation
engineering.
However,
technological
ethical
challenges
hinder
widespread
clinical
application
cells.
review
examines
current
landscape
underscoring
importance
comprehensive
assessments
that
acknowledge
diversity
types
functions.
Additionally,
this
scrutinizes
limitations
prospects
associated
implementation
treatments
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Jan. 12, 2024
Abstract
Although
stem
cell-based
therapy
has
demonstrated
considerable
potential
to
manage
certain
diseases
more
successfully
than
conventional
surgery,
it
nevertheless
comes
with
inescapable
drawbacks
that
might
limit
its
clinical
translation.
Compared
cells,
cell-derived
exosomes
possess
numerous
advantages,
such
as
non-immunogenicity,
non-infusion
toxicity,
easy
access,
effortless
preservation,
and
freedom
from
tumorigenic
ethical
issues.
Exosomes
can
inherit
similar
therapeutic
effects
their
parental
cells
embryonic
adult
through
vertical
delivery
of
pluripotency
or
multipotency.
After
a
thorough
search
meticulous
dissection
relevant
literature
the
last
five
years,
we
present
this
comprehensive,
up-to-date,
specialty-specific
disease-oriented
review
highlight
surgical
application
exosomes.
derived
(e.g.,
embryonic,
induced
pluripotent,
hematopoietic,
mesenchymal,
neural,
endothelial
cells)
are
capable
treating
encountered
in
orthopedic
neurosurgery,
plastic
general
cardiothoracic
urology,
head
neck
ophthalmology,
obstetrics
gynecology.
The
diverse
cells-derived
hierarchical
translation
tissue-specific
responses,
cell-specific
molecular
signaling
pathways.
In
review,
viable
potent
alternative
managing
various
conditions.
We
recommend
future
research
combines
wisdoms
surgeons,
nanomedicine
practitioners,
cell
researchers
intriguing
area.
Stem Cell Research & Therapy,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 26, 2023
Abstract
Wound
healing
is
a
dynamic
and
highly
sequential
process
involving
series
of
overlapping
spatial
temporal
phases,
including
hemostasis,
inflammation,
proliferation,
tissue
remodeling.
Mesenchymal
stem
cells
(MSCs)
are
multipotent
with
self-renewal,
multidirectional
differentiation
potential,
paracrine
regulation.
Exosomes
subcellular
vesicular
components
30–150
nm
in
size
novel
carriers
intercellular
communication
regulating
the
biological
behaviors
skin
cells.
Compared
to
MSCs,
MSC-derived
exosomes
(MSC-exos)
possess
lower
immunogenicity,
easy
storage,
effective
activity.
MSC-exos,
mainly
derived
from
adipose-derived
(ADSCs),
bone
marrow-derived
MSCs
(BMSCs),
human
umbilical
cord
(hUC-MSCs),
other
cell
types,
play
role
shaping
activity
fibroblasts,
keratinocytes,
immune
cells,
endothelial
diabetic
wounds,
inflammatory
wound
repair,
even
wound-related
keloid
formation.
Therefore,
this
study
focuses
on
specific
roles
mechanisms
different
MSC-exos
healing,
as
well
current
limitations
various
perspectives.
Deciphering
properties
crucial
providing
promising
cell-free
therapeutic
tool
for
cutaneous
regeneration.
Graphical
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: July 1, 2024
The
applications
of
hydrogels
have
expanded
significantly
due
to
their
versatile,
highly
tunable
properties
and
breakthroughs
in
biomaterial
technologies.
In
this
review,
we
cover
the
major
achievements
potential
therapeutic
applications,
focusing
primarily
on
two
areas:
emerging
cell-based
therapies
promising
non-cell
modalities.
Within
context
cell
therapy,
discuss
capacity
overcome
existing
translational
challenges
faced
by
mainstream
therapy
paradigms,
provide
a
detailed
discussion
advantages
principal
design
considerations
for
boosting
efficacy
as
well
list
specific
examples
different
disease
scenarios.
We
then
explore
drug
delivery,
physical
intervention
therapies,
other
areas
(e.g.,
bioadhesives,
artificial
tissues,
biosensors),
emphasizing
utility
beyond
mere
delivery
vehicles.
Additionally,
complement
our
latest
progress
clinical
application
outline
future
research
directions,
particularly
terms
integration
with
advanced
biomanufacturing
This
review
aims
present
comprehensive
view
critical
insights
into
selection
both
tailored
meet
requirements
diverse
diseases
situations.
BMEMat,
Journal Year:
2023,
Volume and Issue:
1(3)
Published: July 19, 2023
Abstract
Cell
therapy
has
revolutionized
the
treatment
of
various
diseases,
such
as
cancers,
genetic
disorders,
and
autoimmune
diseases.
Currently,
most
cell
products
rely
on
ex
vivo
engineering,
which
requires
sophisticated
manufacturing
processes
poses
safety
concerns.
The
implementation
in
situ
holds
potential
to
overcome
current
limitations
provides
a
broad
range
applications
clinical
feasibility
future.
A
variety
biomaterials
have
been
developed
improve
function
target
delivery
specific
types
due
their
excellent
biocompatibility,
tunable
properties,
other
functionalities,
provide
reliable
method
achieve
modulation
reprogramming.
In
this
article,
we
summarize
recent
advances
for
including
T
cells,
macrophages,
dendritic
stem
cells
reprogramming
leveraging
lipid
nanoparticles,
polymers,
inorganic
materials,
biomaterials.
Finally,
discuss
challenges
future
perspectives
therapy.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 5, 2024
Diabetic
vascular
complications
are
prevalent
and
severe
among
diabetic
patients,
profoundly
affecting
both
their
quality
of
life
long-term
prospects.
These
can
be
classified
into
macrovascular
microvascular
complications.
Under
the
impact
risk
factors
such
as
elevated
blood
glucose,
pressure,
cholesterol
lipids,
endothelium
undergoes
endothelial
dysfunction,
characterized
by
increased
inflammation
oxidative
stress,
decreased
NO
biosynthesis,
endothelial-mesenchymal
transition,
senescence,
even
cell
death.
processes
will
ultimately
lead
to
diseases,
with
diseases
mainly
atherosclerosis
(AS)
thickening
basement
membrane.
It
further
indicates
a
primary
contributor
morbidity
mortality
observed
in
individuals
diabetes.
In
this
review,
we
delve
intricate
mechanisms
that
drive
dysfunction
during
diabetes
progression
its
associated
Furthermore,
outline
various
pharmacotherapies
targeting
hope
accelerating
effective
therapeutic
drug
discovery
for
early
control
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 571 - 608
Published: Jan. 1, 2024
Abstract:
With
the
development
of
nanotechnology,
nanoparticles
(NPs)
have
shown
broad
prospects
as
drug
delivery
vehicles.
However,
they
exhibit
certain
limitations,
including
low
biocompatibility,
poor
physiological
stability,
rapid
clearance
from
body,
and
nonspecific
targeting,
which
hampered
their
clinical
application.
Therefore,
novel
systems
with
improved
biocompatibility
high
target
specificity
remains
a
major
challenge.
In
recent
years,
biofilm
mediated
biomimetic
nano-drug
system
(BNDDS)
has
become
research
hotspot
focus
in
field
life
sciences.
This
new
platform
uses
bio-nanotechnology
to
encapsulate
synthetic
NPswithin
membrane,
organically
integrating
immunogenicity,
toxicity,
tumor
good
adjustability
versatility
nanocarrier,
shows
promising
applications
precision
therapy.
this
review,
we
systematically
summarize
progress
BNDDS
used
for
optimizing
delivery,
providing
theoretical
reference
designing
safe
efficient
treatment
strategies
improve
outcomes.
Keywords:
nanoparticles,
cell
targeted
therapy
Stem Cell Research & Therapy,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Aug. 26, 2024
Advances
in
stem
cell
technology
offer
new
possibilities
for
patients
with
untreated
diseases
and
disorders.
Stem
cell-based
therapy,
which
includes
multipotent
mesenchymal
cells
(MSCs),
has
recently
become
important
regenerative
therapies.
MSCs
are
progenitor
that
possess
the
ability
to
undergo
vitro
self-renewal
differentiate
into
various
lineages.
have
demonstrated
promise
several
areas,
such
as
tissue
regeneration,
immunological
modulation,
anti-inflammatory
qualities,
wound
healing.
Additionally,
development
of
specific
guidelines
quality
control
methods
ultimately
result
therapeutic
application
been
made
easier
by
recent
advancements
study
MSC
biology.
This
review
discusses
latest
clinical
uses
obtained
from
umbilical
cord
(UC),
bone
marrow
(BM),
or
adipose
(AT)
treating
human
pulmonary
dysfunctions,
neurological
disorders,
endocrine/metabolic
diseases,
skin
burns,
cardiovascular
conditions,
reproductive
this
offers
comprehensive
information
regarding
targeted
therapies
utilizing
MSCs.
It
also
presents
examines
concept
origin
its
potential
impact
on
function
downstream
applications.
The
ultimate
aim
research
is
facilitate
translational
applications
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(6), P. 3562 - 3562
Published: March 21, 2024
Exosomes
are
extracellular
vesicles
of
endosomal
origin,
ranging
from
30
to
150
nm
in
diameter,
that
mediate
intercellular
transfer
various
biomolecules,
such
as
proteins,
lipids,
nucleic
acids,
and
metabolites.
They
modulate
the
functions
recipient
cells
participate
diverse
physiological
pathological
processes,
immune
responses,
cell-cell
communication,
carcinogenesis,
viral
infection.
Stem
(SCs)
pluripotent
or
multipotent
can
differentiate
into
cell
types.
SCs
also
secrete
exosomes,
which
exhibit
remarkable
therapeutic
potential
for
diseases,
especially
field
regenerative
medicine.
For
example,
exosomes
derived
mesenchymal
stem
(MSCs)
contain
miRNAs
ameliorate
endocrine
disorders,
diabetes
cancer.
(sc-exos)
may
offer
similar
advantages
SCs,
but
with
reduced
risks
challenges.
Sc-exos
have
lower
tumorigenicity,
immunogenicity,
infectivity.
deliver
drugs
more
efficiently
penetrate
deeper
tissues.
In
this
review,
we
provide
an
overview
recent
advances
sc-exos
their
applications
We
elucidate
how
biological
effects
depend
on
molecular
composition.
address
current
challenges
future
directions
using
sc-exos.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 743 - 743
Published: March 27, 2024
Mesenchymal
stem
cells
(MSCs)
have
been
recognized
as
a
cell
therapy
with
the
potential
to
promote
skin
healing.
MSCs,
their
multipotent
differentiation
ability,
can
generate
various
related
wound
healing,
such
dermal
fibroblasts
(DFs),
endothelial
cells,
and
keratinocytes.
In
addition,
MSCs
neovascularization,
cellular
regeneration,
tissue
healing
through
mechanisms
including
paracrine
autocrine
signaling.
Due
these
characteristics,
extensively
studied
in
context
of
burn
chronic
repair.
Furthermore,
during
investigation
unique
roles
aging
scarless
also
discovered.
this
review,
we
summarize
by
which
discuss
recent
findings
from
preclinical
clinical
studies.
We
explore
strategies
enhance
therapeutic
effects
MSCs.
Moreover,
emerging
trend
combining
engineering
techniques,
leveraging
advantages
materials,
biodegradable
scaffolds
hydrogels,
repair
capacity
Additionally,
highlight
using
characteristics
cell-free
therapies
future
direction
cell-based
treatments,
further
demonstrating
regenerative
aesthetic
applications
regeneration.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Jan. 3, 2024
Abstract
Cell
and
gene
therapies
hold
tremendous
promise
for
treating
a
range
of
difficult-to-treat
diseases.
However,
concerns
over
the
safety
efficacy
require
to
be
further
addressed
in
order
realize
their
full
potential.
Synthetic
receptors,
synthetic
biology
tool
that
can
precisely
control
function
therapeutic
cells
genetic
modules,
have
been
rapidly
developed
applied
as
powerful
solution.
Delicately
designed
engineered,
they
finetune
activities,
i.e.,
regulate
production
dosed,
bioactive
payloads
by
sensing
processing
user-defined
signals
or
biomarkers.
This
review
provides
an
overview
diverse
receptor
systems
being
used
reprogram
wide
applications
biomedical
research.
With
special
focus
on
four
at
forefront,
including
chimeric
antigen
receptors
(CARs)
Notch
(synNotch)
we
address
generalized
strategies
design,
construct
improve
receptors.
Meanwhile,
also
highlight
expanding
landscape
well
current
challenges
clinical
translation.